InvestSMART

Emyria Limited (ASX: EMD) - Announcements

Current share price for EMD : $0.048 0.001 (2.13%)+

ASX company news and announcements for Emyria Limited (EMD) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emyria Limited (EMD) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emyria Limited (EMD), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emyria Limited (EMD)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$39 Notice of Annual General Meeting/Proxy Form 11 Oct 2024 3:52PM $0.030 $0.048 risen by 60%
$39 Appendix 4G and Corporate Governance Statement 11 Oct 2024 3:50PM $0.030 $0.048 risen by 60%
$39 Annual Report 11 Oct 2024 3:50PM $0.030 $0.048 risen by 60%
$39 Change of Director's Interest Notice x 2 23 Sep 2024 12:38PM $0.037 $0.048 risen by 29.73%
$39 Section 708A(5)(e) Notice 20 Sep 2024 5:26PM $0.037 $0.048 risen by 29.73%
$39 Notification regarding unquoted securities - EMD 20 Sep 2024 5:19PM $0.037 $0.048 risen by 29.73%
$39 Application for quotation of securities - EMD 20 Sep 2024 5:15PM $0.037 $0.048 risen by 29.73%
$39 2024 Annual General Meeting - Key Dates 16 Sep 2024 5:27PM $0.040 $0.048 risen by 20%
$39 Hidden Gems Webinar Presentation 6 Sep 2024 8:58AM $0.046 $0.048 risen by 4.35%
$39 Emyria Shares Interim Success in PTSD Treatment Program 2 Sep 2024 9:50AM $0.032 $0.048 risen by 50%
$39 Appendix 4E & Annual Report for the Year Ended 30 June 2024 30 Aug 2024 2:35PM $0.029 $0.048 risen by 65.52%
$39 Results of Meeting 21 Aug 2024 4:43PM $0.033 $0.048 risen by 45.45%
$39 June 2024 Quarterly Activities Report and Appendix 4C 30 Jul 2024 9:06AM $0.044 $0.048 risen by 9.09%
$39 Letter to Shareholders - Notice of General Meeting 19 Jul 2024 11:08AM $0.046 $0.048 risen by 4.35%
$39 Notice of General Meeting/Proxy Form 19 Jul 2024 11:08AM $0.046 $0.048 risen by 4.35%
$39 Becoming a substantial holder 15 Jul 2024 7:14PM $0.048 $0.048 fallen by 0%
$39 Ceasing to be a substantial holder 15 Jul 2024 7:12PM $0.048 $0.048 fallen by 0%
$39 Emyria, UWA Secure $499K Grant for MDMA Analogue Program 1 Jul 2024 9:30AM $0.041 $0.048 risen by 17.07%
$39 Empax Centre Selected As Key Site In Global PTSD Study 20 Jun 2024 8:21AM $0.046 $0.048 risen by 4.35%
$39 Management Changes 11 Jun 2024 8:22AM $0.055 $0.048 fallen by 12.73%
$39 Change in substantial holding 10 May 2024 8:17AM $0.047 $0.048 risen by 2.13%
$39 Section 708A(5)(e) Notice 7 May 2024 6:42PM $0.050 $0.048 fallen by 4%
$39 Notification regarding unquoted securities - EMD 7 May 2024 6:39PM $0.050 $0.048 fallen by 4%
$39 Application for quotation of securities - EMD 7 May 2024 6:37PM $0.050 $0.048 fallen by 4%
$39 March 2024 Quarterly Activities Report and Appendix 4C 26 Apr 2024 8:40AM $0.051 $0.048 fallen by 5.88%

151 - 175 of 555 results

Page 7 of 23

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.